ClinicalTrials.Veeva

Menu

Role of Colonic Short Chain Fatty Acids in Obesity

U

University of Toronto

Status

Completed

Conditions

Obesity

Treatments

Other: Inulin
Other: Glucose
Other: Resistant Starch

Study type

Interventional

Funder types

Other

Identifiers

NCT02562014
Protocol #27112

Details and patient eligibility

About

The excess production of colonic short-chain-fatty-acids (SCFA) has been implicated in the promotion of obesity, but colonic fermentation of dietary-fiber to SCFA may also play a role in preventing diabetes. The investigators aimed to compare the effects of two fermentable fibers (inulin and resistant-starch) on postprandial SCFA, glucose, insulin, free-fatty acids (FFA) and gut hormone responses and to compare the responses in healthy overweight and obese (OWO) vs lean (LN) participants. Methods: Using a randomized, single blind, crossover design, 13 OWO and 12 LN overnight fasted participants were studied on 3 separate occasions. On each day they consumed a 300 mL drink containing 75g glucose (Control) or 75g glucose plus 24g inulin (IN), or 28.2g resistant-starch (RS). A standard lunch was served 4 h after the test drink.

Enrollment

25 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • non-pregnant
  • body mass index >=20 and <=35

Exclusion criteria

  • history of diabetes mellitus
  • history of cardiovascular disease
  • history of bowel disease
  • history of kidney disease
  • history of liver disease
  • use of antibiotics within 3 months of enrolment
  • unusual dietary habits
  • fasting glucose >6.9mmol/L
  • hematocrit below normal range for age and sex

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

25 participants in 2 patient groups

Lean
Other group
Description:
Participants with body mass index \<=25
Treatment:
Other: Glucose
Other: Inulin
Other: Resistant Starch
Overweight
Other group
Description:
Participants with body mass index \>25
Treatment:
Other: Glucose
Other: Inulin
Other: Resistant Starch

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems